These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 18790510

  • 1. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B.
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [Abstract] [Full Text] [Related]

  • 2. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 3. Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
    Moreau T.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S12-5. PubMed ID: 19200858
    [Abstract] [Full Text] [Related]

  • 4. Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis.
    Miller A, Spada V, Beerkircher D, Kreitman RR.
    Mult Scler; 2008 May 01; 14(4):494-9. PubMed ID: 18208875
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow up of glatiramer acetate compassionate use in Belgium.
    Sindic CJ, Seeldrayers P, Vande Gaer L, De Smet E, Nagels G, De Deyn PP, Medaer R, Guillaume D, D'Hooghe MB, Deville MC, Decoo D, Sadzot B, Van Landegem W, Strauven T, Pepin J, Merckx H, Caekebeke J, van der Tool MA.
    Acta Neurol Belg; 2005 Jun 01; 105(2):81-5. PubMed ID: 16076061
    [Abstract] [Full Text] [Related]

  • 6. Lessons from randomised direct comparative trials.
    Achiron A, Fredrikson S.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S19-24. PubMed ID: 19200860
    [Abstract] [Full Text] [Related]

  • 7. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
    Meca-Lallana JE, de Mingo-Casado P, Amorin-Díaz M, Martínez-Navarro ML, Barreiro AF.
    Clin Ther; 2010 Jun 01; 32(6):1061-6. PubMed ID: 20637960
    [Abstract] [Full Text] [Related]

  • 8. Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data.
    Johnson KP, Ford CC, Lisak RP, Wolinsky JS.
    Acta Neurol Scand; 2005 Jan 01; 111(1):42-7. PubMed ID: 15595937
    [Abstract] [Full Text] [Related]

  • 9. Glatiramer acetate: successful desensitization for treatment of multiple sclerosis.
    Bains SN, Hsieh FH, Rensel MR, Radojicic C, Katz HT, Inamdar SR, Lang DM.
    Ann Allergy Asthma Immunol; 2010 Apr 01; 104(4):321-5. PubMed ID: 20408342
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial.
    Rovaris M, Comi G, Rocca MA, Valsasina P, Ladkani D, Pieri E, Weiss S, Shifroni G, Wolinsky JS, Filippi M, European/Canadian Glatiramer Acetate Study Group.
    Mult Scler; 2007 May 01; 13(4):502-8. PubMed ID: 17483532
    [Abstract] [Full Text] [Related]

  • 11. New options for early treatment of multiple sclerosis.
    Tintoré M.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [Abstract] [Full Text] [Related]

  • 12. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z, Bereczki D, Csiba L, Csépány T.
    Ideggyogy Sz; 2006 Nov 20; 59(11-12):442-7. PubMed ID: 17203882
    [Abstract] [Full Text] [Related]

  • 13. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
    Wolinsky JS, Narayana PA, O'Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani D, PROMiSe Trial Study Group.
    Ann Neurol; 2007 Jan 20; 61(1):14-24. PubMed ID: 17262850
    [Abstract] [Full Text] [Related]

  • 14. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
    Comi G, Filippi M, Wolinsky JS.
    Ann Neurol; 2001 Mar 20; 49(3):290-7. PubMed ID: 11261502
    [Abstract] [Full Text] [Related]

  • 15. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.
    Wolinsky JS, Narayana PA, Johnson KP, Multiple Sclerosis Study Group and the MRI Analysis Center.
    Mult Scler; 2001 Feb 20; 7(1):33-41. PubMed ID: 11321192
    [Abstract] [Full Text] [Related]

  • 16. Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.
    Zwibel HL, Copolymer-1 Treatment Study Principal Investigators.
    Acta Neurol Scand; 2006 Jun 20; 113(6):378-86. PubMed ID: 16674604
    [Abstract] [Full Text] [Related]

  • 17. Long-term effectiveness of glatiramer acetate in clinical practice conditions.
    Arnal-García C, Amigo-Jorrin Mdel C, López-Real AM, Lema-Devesa C, Llopis N, Sanchez-de la Rosa R, XPERIENCIA-5 Study Group.
    J Clin Neurosci; 2014 Dec 20; 21(12):2212-8. PubMed ID: 25257663
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness of glatiramer acetate in clinical practice: an observational study.
    Fernández-Fernández Ó, Garcia-Trujillo L, Guerrero-Fernández M, León A, López-Madrona JC, Alonso A, Bustamante R, Fernández-Sánchez VE.
    Rev Neurol; 2012 Jan 01; 54(1):1-9. PubMed ID: 22187206
    [Abstract] [Full Text] [Related]

  • 19. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 20. Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
    Metz LM, Li D, Traboulsee A, Myles ML, Duquette P, Godin J, Constantin M, Yong VW, GA/minocycline study investigators.
    Mult Scler; 2009 Oct 20; 15(10):1183-94. PubMed ID: 19776092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.